当前位置:首页 - 行情中心 - 南京医药(600713) - 财务分析 - 现金流量表

南京医药

(600713)

  

流通市值:65.63亿  总市值:66.75亿
流通股本:12.87亿   总股本:13.09亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金11,168,439,682.9856,225,650,992.5938,024,329,190.3926,041,227,649.8
收到的税费返还-11,072,232.76--
收到其他与经营活动有关的现金816,533,656.17349,299,958.551,166,791,695.72331,279,087.08
经营活动现金流入的平衡项目0000
经营活动现金流入小计11,984,973,339.1556,586,023,183.939,191,120,886.1126,372,506,736.88
购买商品、接受劳务支付的现金14,888,756,059.8251,301,372,909.6939,771,817,559.8527,052,541,129.76
支付给职工以及为职工支付的现金316,652,576.08978,903,680.85830,823,264.52523,030,315.23
支付的各项税费271,568,974.91,017,753,815.05777,824,373.05522,147,628.72
支付其他与经营活动有关的现金108,434,853.751,152,227,362.91704,487,458.28627,530,719.69
经营活动现金流出的平衡项目0000
经营活动现金流出小计15,585,412,464.5554,450,257,768.542,084,952,655.728,725,249,793.4
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-3,600,439,125.42,135,765,415.4-2,893,831,769.59-2,352,743,056.52
二、投资活动产生的现金流量:
取得投资收益收到的现金690,965.483,342,990.322,030,763.2143,718
处置固定资产、无形资产和其他长期资产收回的现金净额279,461.487,091,022.14,860,572.394,595,918.43
投资活动现金流入的平衡项目0000
投资活动现金流入小计970,426.9610,434,012.426,891,335.594,739,636.43
购建固定资产、无形资产和其他长期资产支付的现金67,566,651.24544,760,104.06478,600,439.59368,274,467.42
投资支付的现金-27,600,00025,200,00025,200,000
支付其他与投资活动有关的现金340,000,000---
投资活动现金流出的平衡项目0000
投资活动现金流出小计407,566,651.24572,360,104.06503,800,439.59393,474,467.42
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-406,596,224.28-561,926,091.64-496,909,104-388,734,830.99
三、筹资活动产生的现金流量:
吸收投资收到的现金-76,718,200735,000-
其中:子公司吸收少数股东投资收到的现金-76,718,200735,000-
取得借款收到的现金6,363,293,333.3416,602,282,765.4112,187,038,200.869,903,679,577.04
发行债券收到的现金1,000,000,0004,499,887,5003,999,887,5002,999,887,500
收到其他与筹资活动有关的现金1,072,528,735.85---
筹资活动现金流入平衡项目0000
筹资活动现金流入小计8,435,822,069.1921,178,888,465.4116,187,660,700.8612,903,567,077.04
偿还债务支付的现金5,492,282,857.2521,282,875,173.9613,544,614,661.489,779,149,772.96
分配股利、利润或偿付利息支付的现金138,936,694.1617,744,311.24546,882,284.52457,519,574.71
其中:子公司支付给少数股东的股利、利润-112,919,162.8484,511,040.3550,796,530
支付其他与筹资活动有关的现金23,820,688.23118,040,978.2896,181,379.9373,332,263.15
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,655,040,239.5822,018,660,463.4814,187,678,325.9310,310,001,610.82
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额2,780,781,829.61-839,771,998.071,999,982,374.932,593,565,466.22
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,226,253,520.07734,067,325.69-1,390,758,498.66-147,912,421.29
加:期初现金及现金等价物余额2,928,136,456.552,194,069,130.862,194,069,130.862,194,069,130.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,701,882,936.482,928,136,456.55803,310,632.22,046,156,709.57
补充资料:
净利润-743,119,993.89-397,544,408.95
资产减值准备-18,267,214.45-4,920,761.62
固定资产和投资性房地产折旧-121,628,563.95-60,884,353.52
无形资产摊销-32,395,107.97-14,647,351.49
长期待摊费用摊销-16,549,417.6-7,993,303.43
处置固定资产、无形资产和其他长期资产的损失--3,852,284.16--4,032,609.86
财务费用-326,276,767.48-170,811,152.15
投资损失--4,018,269.49--1,038,058.45
递延所得税--21,232,042.7--3,426,453.75
其中:递延所得税资产减少--20,464,353.97--4,047,952.12
递延所得税负债增加--767,688.73-621,498.37
存货的减少--502,369,276.16--118,345,392.47
经营性应收项目的减少-454,046,005.51--3,032,986,929.88
经营性应付项目的增加-790,191,969.63-53,225,780.25
现金的期末余额-2,928,136,456.55-2,046,156,709.57
减:现金的期初余额-2,194,069,130.86-2,194,069,130.86
公告日期2025-04-302025-04-102024-10-312024-08-30
审计意见(境内)标准无保留意见
TOP↑